TRT and sexual performance claims: what the data actually shows

What's this video probably claiming?

A TikTok using "stamina," "control in bed," and a 3D animation format is almost certainly pitching testosterone as the fix for sexual performance problems in men. The TRT category tag confirms it. Expect claims that low testosterone causes poor endurance and premature ejaculation, that boosting T levels restores youthful sexual performance, and that hormone optimization is a straightforward path to better sex. The 3D animation format gives the video a clinical veneer, which is a common strategy to make promotional health content look educational. That veneer deserves scrutiny. These videos routinely conflate hypogonadism (a real medical diagnosis) with the general frustration healthy men feel about sexual performance, which are two very different clinical situations.

What does the science actually show?

Testosterone does play a role in libido and erectile function, but the relationship is not linear, and it is not the whole story. The landmark TRAVERSE trial (Lincoff et al., 2023, NEJM) enrolled over 5,200 men with hypogonadism and found testosterone therapy improved sexual function scores modestly, but only in men who were genuinely hypogonadal, defined as total testosterone below 300 ng/dL with confirmed symptoms. A 2016 meta-analysis in the Journal of Sexual Medicine (Corona et al.) covering 14 randomized trials found testosterone improved erectile function primarily in men with documented low T, with effect sizes that were meaningful but not dramatic. On premature ejaculation specifically, which "control in bed" almost certainly references, the evidence connecting low testosterone to PE is thin. Serotonergic pathways and penile sensitivity, not androgen levels, dominate the PE literature.

Where does the social media noise diverge from clinical reality?

The biggest gap is audience targeting. Clinical testosterone therapy is indicated for men with confirmed hypogonadism, typically two early-morning serum testosterone readings below 300 ng/dL combined with symptoms. Most men watching a TikTok about stamina do not have that diagnosis. Yet this content implicitly positions TRT as a performance upgrade for average men, which is a framing that outpaces the evidence considerably. The T-optimization space also routinely ignores suppression of endogenous production. Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis, often reducing sperm production and testicular volume. A 2017 Cochrane review on male hormonal contraception confirmed near-total suppression of spermatogenesis at standard therapeutic doses. That trade-off almost never appears in social content. Neither do polycythemia risks or the complexity of cardiovascular data from TRAVERSE.

What should you actually know?

If you are watching this video because your sexual performance has changed, the first step is not a TRT clinic, it is a proper workup. Erectile dysfunction has cardiovascular overlap that matters clinically. A 2010 analysis in the European Heart Journal (Vlachopoulos et al.) found ED predicts major cardiac events with a hazard ratio of 1.48 independently of traditional risk factors. Premature ejaculation is addressed most effectively with behavioral techniques and, where indicated, dapoxetine or low-dose SSRIs, not hormone therapy. If bloodwork does confirm hypogonadism, TRT is a legitimate, evidence-backed treatment under physician supervision. But "optimizing" testosterone in a eugonadal man for performance reasons is a different claim with weaker evidentiary support and real suppression risks. Be skeptical of any content that skips that distinction.

• TRT is a regulated medical therapy for confirmed hypogonadism, not a general performance supplement.
• The animation format does not make claims more accurate. Judge the evidence, not the production quality.
• Premature ejaculation has its own distinct evidence base that diverges substantially from testosterone research.
• Any TRT discussion that ignores HPG axis suppression is incomplete.